Market Research

Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.

Psychedelics & Aliens: Fiction VS. Facts

Sep 29 • 6 min read

If you dive deep into the underground psychedelic scene, you are bound to encounter some creative theories about aliens. Aliens and psychedelics seem to go together like uncles and inappropriate comments at holiday dinners. Alien enthusiasts have long been labeled as conspiracy theorists. Until recently, believers in extraterrestrial life have been viewed as crazy recluses…

Psychedelic Search Trends & Traffic Analysis: Q3

Sep 28 • 7 min read

The digital world is an integral part of global society, and the online traffic to psychedelic resources can tell us a lot about the state of the industry. Our last psychedelic search trends review and analysis for the psychedelic industry was back in June, so it is about time for an update. We looked at…

Psychedelic Education is Adapting to Meet the Needs of the Modern Psychedelic Industry

Sep 22 • 7 min read

We are a long way from psychedelic-assisted therapy being taught in American colleges and Universities. However, that doesn’t mean there are no psychedelic education resources for therapists seeking the skillsets needed to work these medicines. Psychedelic education resources are growing rapidly to meet the increase in demand for psychedelic therapy. Programs cover a vast spectrum…

Lucy Scientific Discovery: Navigating Growth and Diversification in the Psychedelic and Wellness Sectors

Sep 20 • 6 min read

This has been a busy quarter for the psychedelic industry, particularly Lucy Scientific Discovery Inc. The company has announced three acquisitions in the past three months. These acquisitions create an interesting and unexpected pathway for the company. The NASDAQ-listed Lucy Scientific Discovery has greatly expanded its reach within the psychedelic, wellness, and cannabis industries this…

Lusaris Therapeutics: From Promising Psychedelic Startup to Vanishing Act

Sep 13 • 6 min read

In November 2022, Lusaris Therapeutics made news for its $60 million Series A round. Since then, there has been a curious silence from the company. We recently came across a rumor that the company was shutting down. After a month of attempting to confirm this, we have come up empty-handed. That within itself is strange…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354